Chuangjian Medical is a technological innovation company founded in 2015, with a focus on the creation, sale, and research & development of novel protein- and nucleic acid-based medicines. Their slogan, "Redefining medicine through pioneering protein- and nucleic acid-based treatments," reflects their commitment to innovation in the biopharma and biotechnology industries.
The company recently secured a significant CNY200.00M Series B investment on 16 September 2023. The investors involved in this funding round include L Catterton, CLSA Capital Partners, 深圳市创东方投资有限公司, MingFeng Capital.
Chuangjian Medical's focus on pioneering treatments and the substantial investment received indicate a strong potential for growth and impact in the medical field. As a player in the evolving landscape of biopharma and biotechnology, the company's innovative approach positions it well for future success.
